Unknown

Dataset Information

0

Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation.


ABSTRACT: Haspin is a mitotic protein kinase required for proper cell division by modulating Aurora B kinase localisation and activity as well as histone phosphorylation. Here a series of imidazopyridazines based on the CHR-6494 and Structure Activity Relationship was established. An assessment of the inhibitory activity of the lead structures on human Haspin and several other protein kinases is presented. The lead structure was rapidly optimised using a combination of crystal structures and effective docking models, with the best inhibitors exhibiting potent inhibitory activity on Haspin with IC50 between 6 and 100?nM in vitro. The developed inhibitors displayed anti-proliferative properties against various human cancer cell lines in 2D and spheroid cultures and significantly inhibited the migration ability of osteosarcoma U-2 OS cells. Notably, we show that our lead compounds are powerful Haspin inhibitors in human cells, and did not block G2/M cell cycle transition due to improved selectivity against CDK1/CyclinB.

SUBMITTER: Elie J 

PROVIDER: S-EPMC7580722 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3312407 | BioStudies
2012-01-01 | S-EPMC3288743 | BioStudies
2020-01-01 | S-EPMC7029677 | BioStudies
2010-01-01 | S-EPMC3118465 | BioStudies
2016-01-01 | S-EPMC4854560 | BioStudies
1000-01-01 | S-EPMC4248095 | BioStudies
2018-01-01 | S-EPMC5972072 | BioStudies
1000-01-01 | S-EPMC4083111 | BioStudies
2009-01-01 | S-EPMC2777956 | BioStudies
2018-01-01 | S-EPMC5757254 | BioStudies